Sampaio JP, Gadanho M, Santos M, Duarte FL, Pais C, Fonseca A, Fell JW: Polyphasic taxonomy of the basidiomycetous yeast

genus Rhodosporidium: Rhodosporidium kratochvilovae and related anamorphic species. Int J Syst Evol Microbiol 2001, 51:687–697.PubMed 42. Al-Abeid H, Abu-Elteen K, Elkarmi A, Hamad M: Isolation and characterization of Candida spp. in Jordanian cancer patients: prevalence, pathogenic determinants and antifungal sensitivity. Jpn J Infect Dis 2004, 57:279–284.PubMed Authors’ contributions PS and CP conceived and designed the BKM120 ic50 study. RS, PS, and CC performed the experiments; RS, PS, LR, and CP analyzed the data; RS, PS and CP wrote the manuscript. All authors have read and approved the final version of the manuscript”
“Background Francisella tularensis (FT) is a gram-negative intracellular bacterium that is the causal agent of tularemia. The Francisellaceae family of bacteria has a single genus, Francisella, which has been divided into two species: 1) Francisella philomiragia (a muskrat pathogen) and 2) Francisella tularensis. Francisella tularensis is further subdivided into four subspecies: tularensis

(type A), holarctica (type B), novicida, and mediasiatica [1]. Of these, only subsp. tularensis and subsp. holarctica cause disease in humans [2]. FT tularensis is considered a prime candidate for use as a biological weapon because it is relatively easy to propagate and LEE011 manufacturer disseminate via aerosolization and because of the high morbidity and mortality associated with aerosol infection (LD50<10 CFU) [3, 4]. The live vaccine strain (FT LVS), which was derived from FT holarctica, is only moderately virulent in humans [5] and retains SN-38 molecular weight virulence in mice. Because LVS causes an infection in mice that is similar to the human form of disease, the murine

FT LVS infection model serves as an appropriate animal model of human tularemic disease [6–8]. FT is well adapted for growth and survival within host macrophages, as evidenced by its ability to inhibit phagosome/lysosome fusion and the respiratory burst, and to escape from the phagosome and replicate within the macrophage cytoplasm [9–11]. Moreover, it has been reported that the virulence of FT depends on its ability to escape into the host cytoplasm [10, 12, 13]. However, like many other successful pathogens, the key to the pathogenesis of FT may be in its ability to overcome, Progesterone evade, and/or suppress innate host immune responses. For instance, FT is known to be relatively resistant to cationic antimicrobial peptides (CAMPs), which may in part be responsible for its ability to overcome host innate immunity [14, 15]. In fact, it has been shown that FT mutant strains that are CAMP-sensitive are attenuated for virulence in mice [16, 17]. FT is also able to evade (in part) innate immune detection because its lipopolysaccharide (LPS) has unusual modifications that render it immunologically inert and unable to stimulate TLR4 [17–19].